Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2022 Jul;52(7):e13761.
doi: 10.1111/eci.13761. Epub 2022 Feb 24.

Prognostic significance of blood urea nitrogen/creatinine ratio in chronic HFpEF

Zhe Zhen  1   2   3 , Weihao Liang  1   2   3 , Weiping Tan  4 , Bin Dong  1   2   3 , Yuzhong Wu  1   2   3 , Chen Liu  1   2   3 , Ruicong Xue  1   2   3
Affiliations
Clinical Trial

Prognostic significance of blood urea nitrogen/creatinine ratio in chronic HFpEF

Zhe Zhen et al. Eur J Clin Invest. 2022 Jul.

Abstract

Background: The prognostic significance of blood urea nitrogen (BUN)/creatinine ratio specifically in chronic heart failure with preserved ejection fraction (HFpEF) patients remained unclear. We aimed to evaluate the association of BUN/creatinine ratio (baseline level and visit-to-visit variation) with the risk of adverse clinical outcomes among patients with chronic HFpEF.

Methods and results: This is a secondary analysis of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) trial. Of the enrolled 3445 participants in the TOPCAT trial, associations between BUN/creatinine and clinical outcomes were examined in a subset of 1521 (baseline measurements level) and 1453 (visit-to-visit variation) participants. A multivariable Cox proportional hazard model was used to assess the prognostic significance of BUN/creatinine ratio and BUN/creatinine ratio variation for the prespecified clinical outcomes. A higher BUN/creatinine ratio was associated with a higher risk of all-cause mortality (hazard ratio [HR] = 1.52, 95%CI, 1.21-1.91; p < .001) as well as cardiovascular disease mortality (HR = 1.83, 95%CI, 1.35-2.49; p < .001) in the fully adjusted model. Greater visit-to-visit variability in BUN/creatinine ratio tended to be independently associated with a higher risk of heart failure hospitalization and primary endpoint (p < .001 for both outcomes). Furthermore, those findings were consistent across participants stratified by the presence of chronic kidney disease at baseline.

Conclusions: Higher BUN/creatinine ratio and greater BUN/creatinine ratio variability are independently associated with adverse outcomes in HFpEF participants in the TOPCAT trial.

Keywords: blood urea nitrogen /creatinine ratio; heart failure with preserved ejection fraction; morbidity; prognosis.

PubMed Disclaimer

References

REFERENCES

    1. Senni M, Redfield MM. Heart failure with preserved systolic function. A different natural history? J Am Coll Cardiol. 2001;38(5):1277-1272.
    1. Testani JM, Coca SG, Shannon RP, Kimmel SE, Cappola TP. Influence of renal dysfunction phenotype on mortality in the setting of cardiac dysfunction: analysis of three randomized controlled trials. Eur J Heart Fail. 2011;13(11):1224-1230. 10.1093/eurjhf/hfr123
    1. Sujino Y, Nakano S, Tanno J, et al. Clinical implications of the blood urea nitrogen/creatinine ratio in heart failure and their association with haemoconcentration. ESC Heart Fail. 2019;6(6):1274-1282. 10.1002/ehf2.12531
    1. Vullo-Navich K, Smith S, Andrews M, Levine AM, Tischler JF, Veglia JM. Comfort and incidence of abnormal serum sodium, BUN, creatinine and osmolality in dehydration of terminal illness. Am J Hosp Palliat Care. Mar-Apr. 1998;15(2):77-84. 10.1177/104990919801500205
    1. Pitt B, Pfeffer MA, Assmann SF, et al. Spironolactone for heart failure with preserved ejection fraction. N Engl J Med. 2014;370(15):1383-1392. 10.1056/NEJMoa1313731.

Publication types

LinkOut - more resources